ICICI Bank: Quarterly Result update
24-01-2022

ICICI Bank | Market Cap Rs. 561,676 Cr

CMP 809 | P/B 2.4x FY23

 

Results: ICICI Bank reported year on year growth of 23.4% in its Net Interest Income and Total Income grew by 18% year on year. CASA stood at 45.2% (vs 46% in Q2FY22). 

For financial ratios, click here for 10 year X-ray

 

Key highlights:

  • Overall loan book grew by 16% year on year. Retail loans grew by 18.54% year on year and corporate loan book was grew 9.4% year on year.
  • Overall deposit growth was 12% year on year. 
  • NIM% declined to 3.96% (vs 4% in previous quarter) as share of domestic loans increased versus foreign.
  • And the profit before provisioning grew 25% year on year. The provisions in relation to Covid-19 stood at Rs. 6,425 Cr at the end of quarter. 
  • Asset quality improved as GNPA reduced to 4.1% from 4.4% in previous quarter.
  • Standard restructured book amounted to Rs 9,684 Cr or 1.2% of advances of which 67% are retail borrowers. 
  • Bank had total 5,298 branches and 13,846 ATMs. ~50% of the branches of the bank are in metro and urban areas.

Outlook:

  • Corporate book was driven by disbursements to well-rated corporates according to the stated strategy
  • Credit Cards is improving gradually though remains lower than the Pre-COVID levels. This is likely to improve as the normalcy returns. Cost of deposits has bottomed out. Thus, deployment of liquidity would likely to support the margins.
  • More than 95% of the Retail and Business Banking portfolio being restructured has been secured.
  • The bank reported a strong quarter propelled by impressive core pre-provisioning operating profit and controlled provisions underpinned by robust asset quality. The steady mix of high-yielding portfolio (Retail/Business Banking) and a low-cost liability franchise is fueling steady NII growth. The bank is seeing a strong recovery in business trends across key segments such as Retail, SME, and Business Banking. Fresh slippages have ebbed leading to continued moderation in credit cost, and the bank has been conservative with 80% PCR. The additional COVID-19 provision buffer renders further comfort.

 

Disclosure: MoneyWorks4me's employees may have exposure in the securities mentioned in the above report. For detailed disclosure click here.
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...